We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
5.00 | 0.29% | 1,733.50 | 1,732.50 | 1,733.00 | 1,739.50 | 1,724.50 | 1,733.00 | 4,237,056 | 16:35:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.48 | 71.35B |
TIDMGSK
RNS Number : 3318X
GlaxoSmithKline PLC
20 February 2017
GlaxoSmithKline plc (the 'Company')
Shares withheld or sold to meet tax liabilities
Following the vesting of the pre-tax awards granted in 2014 under the GlaxoSmithKline Deferred Annual Bonus Plan (DABP) on 16 February 2017 and as notified on 17 February 2017, the notifications that follow reflect changes in the interests of Persons Discharging Managerial Responsibilities (PDMRs) in American Depositary Shares (ADSs) of the Company arising from the withholding of ADSs to meet tax liabilities.
Transaction notification
1. Details of PDMR/person closely associated with them ('PCA') ==== ========================================================================= a) Name Dr M M Slaoui ==== ========================== ============================================= b) Position/status Chairman, Global Vaccines ==== ========================== ============================================= c) Initial notification/ Initial notification amendment ==== ========================== ============================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ========================================================================= a) Name GlaxoSmithKline plc ==== ========================== ============================================= b) LEI 5493000HZTVUYLO1D793 ==== ========================== ============================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ========================================================================= a) Description of GlaxoSmithKline plc American Depositary the financial Shares ('ADSs') instrument ISIN: US37733W1053 ==== ========================== ============================================= b) Nature of the The withholding of ADSs to meet tax liabilities transaction further to the vesting of awards granted in 2014 under the Company's 2009 Deferred Annual Bonus Plan-Deferred Bonus and Matching Awards. ==== ========================== ================================================= c) Price(s) and Price(s) Volume(s) volume(s) --------- ----------------- $40.57 9,237 (Deferred) --------- ----------------- $40.57 3,249 (Matching) --------- ----------------- ==== ========================== ============================================= d) Aggregated information Aggregated volume Price 12,486 $40.57 =============================== ============================================= e) Date of the transaction 2017-02-16 ==== ========================== ============================================= f) Place of the n/a transaction ==== ========================== ============================================= 1. Details of PDMR/person closely associated with them ('PCA') ==== ========================================================================== a) Name Mr D E Troy ==== ========================= =============================================== b) Position/status SVP & General Counsel ==== ========================= =============================================== c) Initial notification/ Initial notification amendment ==== ========================= =============================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ========================================================================== a) Name GlaxoSmithKline plc ==== ========================= =============================================== b) LEI 5493000HZTVUYLO1D793 ==== ========================= =============================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ========================================================================== a) Description of GlaxoSmithKline plc American Depositary the financial Shares ('ADSs') instrument ISIN: US37733W1053 ==== ========================= =============================================== b) Nature of the The withholding of ADSs to meet tax liabilities transaction further to the vesting of awards granted in 2014 under the Company's 2009 Deferred Annual Bonus Plan-Deferred Bonus and Matching Awards. ==== ========================= =============================================== c) Price(s) and Price(s) Volume(s) volume(s) --------- ----------------- $40.57 3,280 (Deferred) --------- ----------------- $40.57 1,208 (Matching) --------- ----------------- ==== ========================= =============================================== d) Aggregated information Aggregated volume Price 4,488 $40.57 ============================== =============================================== e) Date of the transaction 2017-02-16 ==== ========================= =============================================== f) Place of the n/a transaction ==== ========================= ===============================================
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHZBLFLDLFBBBK
(END) Dow Jones Newswires
February 20, 2017 09:12 ET (14:12 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions